BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 9606376)

  • 41. Newly developed hepatocellular carcinoma (HCC) in chronic liver disease: MR imaging findings before the diagnosis of HCC.
    Yu JS; Cho ES; Kim KH; Chung WS; Park MS; Kim KW
    J Comput Assist Tomogr; 2006; 30(5):765-71. PubMed ID: 16954925
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
    Hohmann J; Skrok J; Puls R; Albrecht T
    Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Portal vein occlusion or stenosis in patients with hepatolithiasis: observation by multiphasic contrast-enhanced CT.
    Tajima T; Yoshimitsu K; Irie H; Aibe H; Shinozaki K; Nishie A; Asayama Y; Nakayama T; Kakihara D; Honda H
    Clin Radiol; 2005 Apr; 60(4):469-78. PubMed ID: 15767105
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Imaging of Von Meyenburg complexes.
    Pech L; Favelier S; Falcoz MT; Loffroy R; Krause D; Cercueil JP
    Diagn Interv Imaging; 2016 Apr; 97(4):401-9. PubMed ID: 26522945
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of hepatic lesions in candidates for surgery: comparison of ferumoxides-enhanced MR imaging and dual-phase helical CT.
    Bluemke DA; Paulson EK; Choti MA; DeSena S; Clavien PA
    AJR Am J Roentgenol; 2000 Dec; 175(6):1653-8. PubMed ID: 11090399
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fontan-associated liver disease: Spectrum of US findings.
    Bae JM; Jeon TY; Kim JS; Kim S; Hwang SM; Yoo SY; Kim JH
    Eur J Radiol; 2016 Apr; 85(4):850-6. PubMed ID: 26971434
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Peripheral cholangiocarcinoma: comparison of MRI with CT.
    Choi BI; Han JK; Shin YM; Baek SY; Han MC
    Abdom Imaging; 1995; 20(4):357-60. PubMed ID: 7549743
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The integrated diagnosis of hepatic focal nodular hyperplasia: echography, color Doppler, computed tomography and magnetic resonance compared].
    De Gaetano A; De Franco A; Maresca G; Manfredi R; Barbaro B; Monteforte MG
    Radiol Med; 1996 Mar; 91(3):258-69. PubMed ID: 8628940
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MR imaging with i.v. superparamagnetic iron oxide: efficacy in the detection of focal hepatic lesions.
    Winter TC; Freeny PC; Nghiem HV; Mack LA; Patten RM; Thomas CR; Elliott S
    AJR Am J Roentgenol; 1993 Dec; 161(6):1191-8. PubMed ID: 8249724
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The radiologic and pathologic spectrum of biliary hamartomas.
    Lev-Toaff AS; Bach AM; Wechsler RJ; Hilpert PL; Gatalica Z; Rubin R
    AJR Am J Roentgenol; 1995 Aug; 165(2):309-13. PubMed ID: 7618546
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Spectrum of appearances on CT and MRI of hepatic epithelioid hemangioendothelioma.
    Zhou L; Cui MY; Xiong J; Dong Z; Luo Y; Xiao H; Xu L; Huang K; Li ZP; Feng ST
    BMC Gastroenterol; 2015 Jun; 15():69. PubMed ID: 26088585
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of focal liver lesions with superparamagnetic iron oxide-enhanced MR imaging: value of distributional phase T1-weighted imaging.
    Lee JM; Kim CS; Youk JH; Lee MS
    Korean J Radiol; 2003; 4(1):9-18. PubMed ID: 12679629
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cystic focal liver lesions in the adult: differential CT and MR imaging features.
    Mortelé KJ; Ros PR
    Radiographics; 2001; 21(4):895-910. PubMed ID: 11452064
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Non-neoplastic hepatic vascular diseases: spectrum of CT and MRI appearances.
    Virmani V; Ramanathan S; Virmani VS; Kielar A; Sheikh A; Ryan J
    Clin Radiol; 2014 May; 69(5):538-48. PubMed ID: 24581966
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acute extrahepatic infectious or inflammatory diseases are a cause of transient mosaic pattern on CT and MR imaging related to sinusoidal dilatation of the liver.
    Ronot M; Kerbaol A; Rautou PE; Brancatelli G; Bedossa P; Cazals-Hatem D; Valla DC; Vilgrain V
    Eur Radiol; 2016 Sep; 26(9):3094-101. PubMed ID: 26615556
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ring enhancement in ultrasmall superparamagnetic iron oxide MR imaging: a potential new sign for characterization of liver lesions.
    Mergo PJ; Helmberger T; Nicolas AI; Ros PR
    AJR Am J Roentgenol; 1996 Feb; 166(2):379-84. PubMed ID: 8553952
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of malignant biliary obstruction: efficacy of fast multiplanar spoiled gradient-recalled MR imaging vs spin-echo MR imaging, CT, and cholangiography.
    Low RN; Sigeti JS; Francis IR; Weinman D; Bower B; Shimakawa A; Foo TK
    AJR Am J Roentgenol; 1994 Feb; 162(2):315-23. PubMed ID: 8310918
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Small hyperintense hepatic lesions on T1-weighted images in patients with cirrhosis: evaluation with serial MRI and imaging features for clinical benignity.
    Shimizu A; Ito K; Sasaki K; Hayashida M; Tanabe M; Shimizu K; Matsunaga N
    Magn Reson Imaging; 2007 Dec; 25(10):1430-6. PubMed ID: 17524587
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Primary malignant liver tumors in childhood: assessment of resectability with high-field MR and comparison with CT.
    Finn JP; Hall-Craggs MA; Dicks-Mireaux C; Spitz L; Howard ER; Pritchard J; Vergani GM
    Pediatr Radiol; 1990; 21(1):34-8. PubMed ID: 2287536
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation.
    Maetani Y; Itoh K; Watanabe C; Shibata T; Ametani F; Yamabe H; Konishi J
    AJR Am J Roentgenol; 2001 Jun; 176(6):1499-507. PubMed ID: 11373220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.